🔎 Trials Near Me

Gara Jalqabaatti › Sirna Itti-Fageenyaa fi Haala Itti › Texas

Qorannoo klinikaalii Sirna Itti-Fageenyaa fi Haala Itti Texas keessatti

Qorannoo 14 Sirna Itti-Fageenyaa fi Haala Itti f Texas keessatti hirmaatuu jiru.

Magaalota Texas keessatti

Takkalaa qorannoo (Ingiliffa)

Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  • The Don and Sybil Harrington Cancer Center, Amarillo
  • Audie L Murphy VA Hospital, San Antonio
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin hundi · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04242095

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • The University of Texas - MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07192471

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

  • Jade Clinical Site, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 60 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07541287

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Baylor College of Medicine, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Ful-2026 · NCT06722235

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

  • The University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT04996875

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • Baylor College of Medicine, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ful-2026 · NCT06948318

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Baylor University Medical Center, Dallas
  • Texas Transplant Institute, San Antonio
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • Dallas Renal Group, Dallas
  • Dallas Renal Group, Dallas
  • Nephro Asso North Illinois Indiana, Houston
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06858319

Music-4-MS to Improve Cognition in People Living With Multiple Sclerosis: A Feasibility Study

  • University of Texas at Austin, Austin
Namoota walitti qabaa jira
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT07759115

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

  • Inmagene Site 8, Southlake
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 74 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT07037901

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

  • Texas Children's Hospital, Houston
Namoota walitti qabaa jiraSadarkaa 2
Umuriin hundi · Saalaa hunda · Haaromfame 02-Wax-2026 · NCT05787574

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

  • UT Southwestern Medical Center, Dept. of Dermatology, Dallas
  • MD Anderson Texas Medical Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT04422912

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • The University of Texas MD Anderson Cancer Center, Houston
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

  • St. David's South Austin Medical Center, Austin
  • UT Southwestern Medical Center, Dallas
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Mud-2025 · NCT06619561

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.